Vahanian & Associates Financial Planning’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $113K | Sell |
10,000
-3,760
| -27% | -$42.3K | 0.44% | 47 |
|
|
2023
Q3 | $35.8K | Buy |
+13,760
| New | +$35.8K | 0.11% | 60 |
|
|
2023
Q2 | – | Sell |
-21,430
| Closed | -$90.4K | – | 55 |
|
|
2023
Q1 | $90.4K | Buy |
21,430
+4,300
| +25% | +$18.1K | 0.25% | 73 |
|
|
2022
Q4 | $282K | Sell |
17,130
-250
| -1% | -$4.11K | 0.92% | 40 |
|
|
2022
Q3 | $222K | Buy |
+17,380
| New | +$222K | 0.76% | 44 |
|
|
2022
Q2 | – | Sell |
-31,426
| Closed | -$191K | – | 38 |
|
|
2022
Q1 | $191K | Buy |
+31,426
| New | +$191K | 0.44% | 57 |
|